Manufacturer: USV Ltd
Salt Composition : Vildagliptin(50mg)
Strip of 15 Tablet
(Inclusive of all taxes)
Jalra 50mg Tablet is normally prescribed when diet and exercise alone or other medicines do not prove sufficient to control your blood sugar level. It may prescribe alone or in combination with other diabetes medicines. It can be taken with or without food. The dose will depend on your condition and blood sugar levels. Use it strictly as advised by your doctor.
Vildagliptin binds covalently to the catalytic site of DPP-4, eliciting prolonged enzyme inhibition. This raises intact GLP-1 levels, both after meal ingestion and in the fasting state. Vildagliptin has been shown to stimulate insulin secretion and inhibit glucagon secretion in a glucose-dependent manner
Vildagliptin was rapidly absorbed, exhibiting a median tmax of 1.5 to 2 hours at all doses. Across the dose range of 25 to 200 mg, mean elimination half-life (t1/2) showed a trend toward increased values with increasing dose (1.6-2.5 hours).
Hypoglycemia (low blood glucose level)
Tremors
Headache
Dizziness
Fatigue
Nausea
Contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, severe liver impairment, during pregnancy and breastfeeding
Jalra 50mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
It is not known whether it is safe to consume alcohol with Jalra 50mg Tablet. Please consult your doctor.
Jalra 50mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Vildagliptin is indicated in the treatment of type II diabetes mellitus in adults. As monotherapy, vildagliptin is indicated in adults inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance
The therapeutic efficacy of Vildagliptin can be increased when used in combination with Gemifloxacin. Vildagliptin may increase the hypoglycemic activities of Gliclazide. Vildagliptin may increase the hypoglycemic activities of Glimepiride. Vildagliptin may increase the hypoglycemic activities of Glipizide
Do not chew, crush or break it. Jalra 50mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Store below 30°C
If you miss a dose of Jalra 50mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Consult a doctor before taking any medicines
Jalra 50mg Tablet should be taken at the same time every day since this helps you remember to take it.
It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms such as cold sweats, cool pale skin, tremor and anxiety.
Be careful while driving or operating machinery until you know how Jalra 50mg Tablet affects you.
Your doctor may check your kidney and liver function before starting treatment and regularly thereafter. Inform your doctor if you develop symptoms such as abdominal pain, fatigue, loss of appetite, darkened urine or yellowing of the eyes or skin (jaundice).
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jalra 50mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Q. When should I take Jalra 50mg Tablet?
You can take Jalra 50mg Tablet tablets before, with or after meals. If you have been prescribed to take this medicine once daily, then take it in the morning. In case you have to take it twice daily, then you should prefer taking the first dose in the morning and the second dose in the evening.
Q. Does Jalra 50mg Tablet cause hypoglycemia?
Yes, Jalra 50mg Tablet may cause hypoglycemia (low blood sugar), but the chances are lesser as compared to other antidiabetic drugs. Evidence suggests that treatment with Jalra 50mg Tablet has been shown to cause hypoglycemia in very rare cases. The risk is low even in those who are prone to hypoglycemia like elderly people or people being treated with insulin. However, the chance of hypoglycemia increases if Jalra 50mg Tablet is taken along with other antidiabetic drugs.
Q. Does Jalra 50mg Tablet cause weight gain?
No, Jalra 50mg Tablet does not cause weight gain. Moreover, medicines, such as Jalra 50mg Tablet, are generally supposed to decrease weight since they act by increasing satiety (feeling of fullness) and delaying emptying of the stomach. This further decreases hunger, restricting the patient from eating more than required.
Q. Is Jalra 50mg Tablet the same as sitagliptin?
No, Jalra 50mg Tablet is not the same as Sitagliptin, but both drugs belong to the same class. Additionally, these two drugs have a similar mechanism of decreasing blood glucose levels.
